Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice

被引:32
作者
Bajaj, Jasmohan S. [1 ,2 ]
Bloom, Patricia Pringle [3 ,4 ]
Chung, Raymond T. [3 ,4 ]
Hassanein, Tarek I. [5 ]
Padilla-Martinez, Marielys [5 ]
Kayali, Zeid [6 ]
Rockey, Don C. [7 ]
Sasso, Roula [7 ]
Muthukumar, Alagar R. [8 ]
Lee, William M. [8 ]
Denney, William S. [9 ]
Gavis, Edith A. [1 ,2 ]
Anderson, Cami [10 ]
Blankstein, Larry [10 ]
Brennan, Aoife M. [10 ]
Puurunen, Marja K. [10 ]
Lawitz, Eric [11 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA 23298 USA
[2] McGuire VA Med Ctr, Richmond, VA 23249 USA
[3] Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, GI Div, Boston, MA 02114 USA
[5] Southern Calif Res Ctr, Coronado, CA USA
[6] Inland Empire Liver Fdn, Rialto, CA USA
[7] Med Univ South Carolina, Charleston, SC 29425 USA
[8] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[9] Human Predict LLC, Cambridge, MA USA
[10] Synlogic Inc, Cambridge, MA USA
[11] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA
关键词
HEPATIC-ENCEPHALOPATHY; INTERNATIONAL SOCIETY; CHALLENGE; MODEL;
D O I
10.14309/ajg.0000000000000384
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Ammonia levels are used to assess hepatic encephalopathy, but their levels are highly variable in clinical practice. Methods: We studied factors associated with variation in ammonia values in cirrhotic patients without previous hepatic encephalopathy and healthy volunteers (HVs). Results: Ammonia increased by 12% and 18% at 1 and 2 hour, respectively, after a protein meal in 64 cirrhotic patients (P< 0.001). In 237 HVs, ammonia levels varied significantly between sites (P< 0.0001). New site-specific ammonia upper limits based on HV levels using a strict analysis protocol differed from routinely used values. Correlation between paired fresh samples was high (r = 0.83) but modest between fresh and frozen samples (r = 0.62). Discussion: Sample handling, processing, and protein intake impact ammonia levels across sites.
引用
收藏
页码:783 / 785
页数:3
相关论文
共 9 条
  • [1] The Nutritional Management of Hepatic Encephalopathy in Patients With Cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus
    Amodio, Piero
    Bemeur, Chantal
    Butterworth, Roger
    Cordoba, Juan
    Kato, Akinobu
    Montagnese, Sara
    Uribe, Misael
    Vilstrup, Hendrik
    Morgan, Marsha Y.
    [J]. HEPATOLOGY, 2013, 58 (01) : 325 - 336
  • [2] Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement
    Bajaj, J. S.
    Cordoba, J.
    Mullen, K. D.
    Amodio, P.
    Shawcross, D. L.
    Butterworth, R. F.
    Morgan, M. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (07) : 739 - 747
  • [3] Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy
    Douglass, A
    Al Mardini, H
    Record, C
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (05) : 658 - 664
  • [4] Serum Ammonia Level for the Evaluation of Hepatic Encephalopathy
    Ge, Phillip S.
    Runyon, Bruce A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (06): : 643 - 644
  • [5] ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
    Kwo, Paul Y.
    Cohen, Stanley M.
    Lim, Joseph K.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (01) : 18 - 35
  • [6] Correlation between ammonia levels and the severity of hepatic encephalopathy
    Ong, JP
    Aggarwal, A
    Krieger, D
    Easley, KA
    Karafa, MT
    Van Lente, F
    Arroliga, AC
    Mullen, KD
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 114 (03) : 188 - 193
  • [7] Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy
    Romero-Gómez, M
    Grande, L
    Camacho, I
    [J]. HEPATOLOGY, 2004, 39 (04) : 939 - 943
  • [8] Changes in international normalized ratio (INR) and Model for Endstage Liver Disease (MELD) based on selection of clinical laboratory
    Trotter, J. F.
    Olson, J.
    Lefkowitz, J.
    Smith, A. D.
    Arjal, R.
    Kenison, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (06) : 1624 - 1628
  • [9] Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
    Vilstrup, Hendrik
    Amodio, Piero
    Bajaj, Jasmohan
    Cordoba, Juan
    Ferenci, Peter
    Mullen, Kevin D.
    Weissenborn, Karin
    Wong, Philip
    [J]. HEPATOLOGY, 2014, 60 (02) : 715 - 735